Bandi di ricerca
Bando 2011 per il Biennio 2012-2013
Innovative treatments for neurometabolic and neurogenetic diseases and their complications
Targeting the endo-lysosomal system: development of novel therapeutic strategies to ameliorate neuropathology in lysosomal storage disorders
ALESSANDRO FRALDI, Istituto Telethon di Genetica e Medicina (TIGEM), Napoli
Drug repositioning in rho-linked cognitive impairment: Fasudil, a rock inhibitor as potential treatment in OPHN1 syndrome
ENRICO BERTINI, Ospedale Bambino Gesù, Unità Operativa delle Malattie Muscolari e Neurodegenerative, Laboratorio di Medicina Molecolare, Roma
Novel treatment for a genetic drug-resistant epileptic encephalopathy of infancy: virus delivered RNA interference in an animal model of Dravet syndrome
SILVANA FRANCESCHETTI, Fondazione IRCCS Istituto Neurologico “Carlo Besta”, Dipartimento di Neurofidiopatologia e Centro per l’Epilessia, Milano
Neurological and visual impairment in Cobalamin C defect: a novel therapeutical approach based on antioxidant therapy
CARLO DIONISI-VICI, Ospedale Bambino Gesù, Dipartimento di Pediatria, Unità Operativa di Patologia Metabolica, Roma
